Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review

Combining intraoperative carmustine wafers and Stupp regimen in multimodal first-line treatment of primary glioblastomas

(2015) Vladislav Pavlov et al.   BRITISH JOURNAL OF NEUROSURGERY

BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial

(2015) Stuart H. Burri et al.   JOURNAL OF NEURO-ONCOLOGY

Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis

(2015) Sajeel A. Chowdhary et al.   JOURNAL OF NEURO-ONCOLOGY

Polymeric drug delivery for the treatment of glioblastoma

(2015) S. D. Wait et al.   NEURO-ONCOLOGY

Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort

(2015) Johan Pallud et al.   NEURO-ONCOLOGY

Risk of surgical site infection in 401 consecutive patients with glioblastoma with and without carmustine wafer implantation

(2015) Kaisorn L. Chaichana et al.   NEUROLOGICAL RESEARCH

The role of cytotoxic chemotherapy in the management of progressive glioblastoma

(2014) Jeffrey J. Olson et al.   JOURNAL OF NEURO-ONCOLOGY

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

(2014) Roger Stupp et al.   LANCET ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011

(2014) Q. T. Ostrom et al.   NEURO-ONCOLOGY

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

(2014) Mark R. Gilbert et al.   NEW ENGLAND JOURNAL OF MEDICINE

The role of Gliadel wafers in the treatment of high-grade gliomas

(2013) Amade Bregy et al.   Expert Review of Anticancer Therapy

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

(2013) Mark R. Gilbert et al.   JOURNAL OF CLINICAL ONCOLOGY

The Role of MGMT Testing in Clinical Practice

(2013) Milena Cankovic et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

A Multicenter Phase I/II Study of the BCNU Implant (Gliadel® Wafer) for Japanese Patients with Malignant Gliomas

(2013) Tomokazu AOKI et al.   NEUROLOGIA MEDICO-CHIRURGICA

Implanted Carmustine Wafers Followed by Concomitant Radiochemotherapy to Treat Newly Diagnosed Malignant Gliomas: Prospective, Observational, Multicenter Study on 92 Cases

(2012) Julien Duntze et al.   ANNALS OF SURGICAL ONCOLOGY

O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy w

(2012) Emmanuèle Lechapt-Zalcman et al.   CANCER

Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: Efficacy and toxicity

(2012) Petra Miglierini et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Adult glioblastoma multiforme survival in the temozolomide era: A population-based analysis of Surveillance, Epidemiology, and End Results registries

(2011) Amy S. Darefsky et al.   CANCER

Retrospective Comparison of Chemoradiotherapy Followed by Adjuvant Chemotherapy, With or Without Prior Gliadel Implantation (Carmustine) After Initial Surgery in Patients With Newly Diagnosed High-Grade Gliomas

(2011) Georges Noël et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Biodegradable Carmustine Wafers (Gliadel) Alone or in Combination with Chemoradiotherapy: The French Experience

(2010) Philippe Menei et al.   ANNALS OF SURGICAL ONCOLOGY

First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience

(2010) Hans Christoph Bock et al.   NEUROSURGICAL REVIEW

Risk Management in the Treatment of Malignant Gliomas with BCNU Wafer Implants

(2010) A. Giese et al.   Central European neurosurgery

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience

(2008) Frank J. Attenello et al.   ANNALS OF SURGICAL ONCOLOGY

Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience

(2008) Michael Sabel et al.   CURRENT MEDICAL RESEARCH AND OPINION

Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme

(2008) Camilo E. Fadul et al.   JOURNAL OF NEURO-ONCOLOGY

A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients

(2008) Edward Pan et al.   JOURNAL OF NEURO-ONCOLOGY

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

(2008) Matthew J. McGirt et al.   JOURNAL OF NEUROSURGERY